Hantavirus mucosal vaccine through different mucosal with heat-labile enterotoxin B subunit as adjuvants / 中华实验和临床病毒学杂志
Chinese Journal of Experimental and Clinical Virology
;
(6): 174-176, 2008.
Article
in Chinese
| WPRIM
| ID: wpr-254113
ABSTRACT
<p><b>OBJECTIVE</b>To evaluation the effect of different mucosal vaccination pathway on hantavirus with the recombinant E. coli heat-labile enterotoxin B subunit (rLTB) as adjuvant.</p><p><b>METHODS</b>The rLTB was expressed and purified. Take the inactivated hantavirus strain 84Fli as vaccine, and immunized C57 BL/6 mice through intranasal, oral and vaginal respectively. Specific IgG and sectory IgA were detected by ELISA in serum, and vaginal washing samples respectively.</p><p><b>RESULTS</b>The rLTB was efficiently expressed under the induction of lactose, identified by western blotting and GM-1 binding experiment. The vaccination through intranasal, oral and vaginal, can induce IgG and sectory IgA response.</p><p><b>CONCLUSION</b>Inactivated hantavirus can produce mucosal immune response with rLTB as adjuvants through intranasal, oral and vaginal vaccination respectively.</p>
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Bacterial Toxins
/
Virology
/
Blood
/
Immunoglobulin A
/
Immunoglobulin G
/
Viral Vaccines
/
Random Allocation
/
Adjuvants, Immunologic
/
Orthohantavirus
/
Hantavirus Infections
Type of study:
Controlled clinical trial
Limits:
Animals
/
Female
/
Humans
Language:
Chinese
Journal:
Chinese Journal of Experimental and Clinical Virology
Year:
2008
Type:
Article
Similar
MEDLINE
...
LILACS
LIS